{
  "id": "76bcbcc478f4b352",
  "title": "RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS : REVENUE +11 . 8 %, EBITDA ( 1 ) +14 . 5 %, ADJUSTED NET INCOME ( 2 ) +14 . 5 % | Company Announcement",
  "description": "20260217T191500Z",
  "content": "",
  "source": "investegate.co.uk",
  "source_url": "https://www.investegate.co.uk/announcement/gnw/recordti-industria-chimica-e-farma--0kbs/recordati-reports-strong-preliminary-full-yea-/9435045",
  "published_at": "20260217T191500Z",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United Kingdom",
  "raw_data": {
    "url": "https://www.investegate.co.uk/announcement/gnw/recordti-industria-chimica-e-farma--0kbs/recordati-reports-strong-preliminary-full-yea-/9435045",
    "url_mobile": "",
    "title": "RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS : REVENUE +11 . 8 %, EBITDA ( 1 ) +14 . 5 %, ADJUSTED NET INCOME ( 2 ) +14 . 5 % | Company Announcement",
    "seendate": "20260217T191500Z",
    "socialimage": "",
    "domain": "investegate.co.uk",
    "language": "English",
    "sourcecountry": "United Kingdom"
  }
}